{"id":633,"date":"2025-10-02T03:50:48","date_gmt":"2025-10-02T03:50:48","guid":{"rendered":"https:\/\/www.thebrokeronline.eu\/pender-jon\/"},"modified":"2025-10-02T03:50:48","modified_gmt":"2025-10-02T03:50:48","slug":"pender-jon","status":"publish","type":"page","link":"https:\/\/www.thebrokeronline.eu\/authors\/pender-jon\/","title":{"rendered":"Pender Jon"},"content":{"rendered":"<div class=\"middle content\">\n<div class=\"column left\" id=\"columnleft\">\n<section class=\"block article author\">\n<div class=\"headline\">\n<h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\tJon Pender<br \/>\n\t\t\t\t\t\t\t\t\t\t<\/h3>\n<\/p><\/div>\n<div class=\"inline-content\">\n<div class=\"about-author\">\n<div class=\"img border\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.thebrokeronline.eu\/files\/var\/broker\/storage\/images\/authors\/pender-jon\/661112-1-eng-gb\/pender-jon_author.jpg\" alt=\"Pender Jon\">\n\t\t\t\t\t\t<\/div>\n<p class=\"yunu3cvqabft7vifv\">Jon&nbsp;Pender&nbsp;is vice president for IP &#038; access, global health, in GlaxoSmithKline\u2019s Government Affairs Department. He is responsible for ensuring that GSK\u2019s approach to sustainably improving access to medicines in the developing world reaches as many people in need as possible, whilst protecting the fundamental business model which underpins the research-based pharmaceutical industry.&nbsp;<\/p>\n<div style=\"clear:both\"><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/section>\n<div class=\"clear\"><\/div>\n<div class=\"clear\"><\/div>\n<\/p><\/div>\n<section class=\"content column wide left author content view\" id=\"content\">\n<article class=\"fader\">\n<div class=\"article\">\n<div class=\"body contents\">\n<div class=\"share\">\n\t\t\t\t<script type=\"text\/javascript\">\n    var addthis_config = {\n        ui_language = 'en'\n    }\n<\/script><\/p>\n<div class=\"addthis sharing\">\n\t<!-- AddThis Button BEGIN --><\/p>\n<div class=\"addthis_toolbox addthis_default_style addthis_32x32_style\" addthis:title=\"Pender Jon\">\n\t<a class=\"addthis_button_twitter\" tw:via=\"thebrokeronline\"><\/a><br \/>\n\t<a class=\"addthis_button_facebook\"><\/a><br \/>\n\t<a class=\"addthis_button_pinterest_share\"><\/a><br \/>\n\t<a class=\"addthis_button_preferred_4\"><\/a><br \/>\n\t<a class=\"addthis_button_compact\"><\/a><br \/>\n\t<a class=\"addthis_counter addthis_bubble_style\"><\/a>\n\t<\/div>\n<p>\t<script type=\"text\/javascript\">var addthis_config = data_track_addressbar;<\/script><br \/>\n\t<script type=\"text\/javascript\" src=\"https:\/\/www.thebrokeronline.eu\/files\/js\/300\/addthis_widget.js\"><\/script><br \/>\n\t<!-- AddThis Button END -->\n<\/div>\n<div class=\"addthis article_options\">\n<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"children\">\n<div class=\"article\">\n<section class=\"children related\">\n<div class=\"article\">\n<div class=\"wleft\">\n<div class=\"img\">\n\t\t\t\t\t<a href=\"https:\/\/www.thebrokeronline.eu\/blogs\/post-2015-shaping-a-global-agenda\/the-value-of-corporate-partnerships\/\"><br \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.thebrokeronline.eu\/files\/var\/broker\/storage\/images\/blogs\/post-2015-shaping-a-global-agenda\/the-value-of-corporate-partnerships\/661126-1-eng-gb\/the-value-of-corporate-partnerships_column.jpg\" alt=\"The value of corporate partnerships\"><br \/>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<div class=\"wright\">\n<header>\n<h3><a href=\"https:\/\/www.thebrokeronline.eu\/blogs\/post-2015-shaping-a-global-agenda\/the-value-of-corporate-partnerships\/\">The value of corporate partnerships<\/a><\/h3>\n<p>\t\t\t\t\t\t\t<a href=\"https:\/\/www.thebrokeronline.eu\/authors\/pender-jon\/\">Jon Pender<\/a>\t\t\t\t\t|<br \/>\n\t\t\t\t\t\t\t11 November 2025<br \/>\n\t\t\t\t\t<\/header>\n<p class=\"yunu3cvqabft7vifv\">\n\t\t\tPartnerships between the private sector and like-minded organizations are key to securing genuine and lasting change in global development.\n\t\t<\/p>\n<p>\t\t\t\t<a class=\"more\" href=\"https:\/\/www.thebrokeronline.eu\/blogs\/post-2015-shaping-a-global-agenda\/the-value-of-corporate-partnerships\/\">read more<\/a>\n\t<\/div>\n<div class=\"clear\"><\/div>\n<\/div>\n<\/section><\/div>\n<\/p><\/div>\n<div class=\"navigator\">\n\t\t<\/div>\n<\/article>\n<div class=\"clear\"><\/div>\n<\/section><\/div>\n<div class=\"clear\"><\/div>\n","protected":false,"raw":""},"excerpt":{"rendered":"<p>Jon Pender Jon&nbsp;Pender&nbsp;is vice president for IP &#038; access, [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template_3.php","meta":{"footnotes":""},"class_list":["post-633","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pender Jon \/ Authors - The Broker<\/title>\n<meta name=\"description\" content=\"Jon&amp;nbsp;Pender&amp;nbsp;is vice president for IP &amp;amp; access, global health, in GlaxoSmithKline\u00e2\u20ac\u2122s Government Affairs Department.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thebrokeronline.eu\/authors\/pender-jon\/\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pender Jon \/ Authors - The Broker\" \/>\n<meta property=\"og:description\" content=\"Jon&amp;nbsp;Pender&amp;nbsp;is vice president for IP &amp;amp; access, global health, in GlaxoSmithKline\u00e2\u20ac\u2122s Government Affairs Department.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thebrokeronline.eu\/authors\/pender-jon\/\" \/>\n<meta property=\"og:site_name\" content=\"Homepage - Broker Online\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pender Jon \/ Authors - The Broker","description":"Jon&amp;nbsp;Pender&amp;nbsp;is vice president for IP &amp;amp; access, global health, in GlaxoSmithKline\u00e2\u20ac\u2122s Government Affairs Department.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thebrokeronline.eu\/authors\/pender-jon\/","og_type":"article","og_title":"Pender Jon \/ Authors - The Broker","og_description":"Jon&amp;nbsp;Pender&amp;nbsp;is vice president for IP &amp;amp; access, global health, in GlaxoSmithKline\u00e2\u20ac\u2122s Government Affairs Department.","og_url":"https:\/\/www.thebrokeronline.eu\/authors\/pender-jon\/","og_site_name":"Homepage - Broker Online","twitter_card":"summary_large_image"},"_links":{"self":[{"href":"https:\/\/www.thebrokeronline.eu\/wp-json\/wp\/v2\/pages\/633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thebrokeronline.eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.thebrokeronline.eu\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thebrokeronline.eu\/wp-json\/wp\/v2\/comments?post=633"}],"version-history":[{"count":0,"href":"https:\/\/www.thebrokeronline.eu\/wp-json\/wp\/v2\/pages\/633\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.thebrokeronline.eu\/wp-json\/wp\/v2\/media?parent=633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}